Literature DB >> 1583890

Development and application of a radioimmunoassay for interleukin-8: detection of interleukin-8 in synovial fluids from patients with inflammatory joint disease.

M Rampart1, A G Herman, B Grillet, G Opdenakker, J Van Damme.   

Abstract

A sensitive and specific radioimmunoassay for human interleukin-8 (IL-8) was developed using isotopically labeled homogenous natural protein. The detection limit (20% inhibition of 125I-IL-8 binding) was 30 pg/100 microliters; 50% displacement occurred at 140 pg/100 microliters. There was no cross-reactivity with the structurally and functionally related neutrophil-activating peptides 2 and 3 up to 500 ng/100 microliters. The intra- and inter-assay coefficients of variation were 4 and 7%, respectively. In vitro experiments showed that human fibroblasts triggered by interleukin-1, double-stranded RNA or virus release immunoreactive and biologically active IL-8 in a dose- and time-dependent manner. Monocytes produce immunoreactive IL-8 in the 100 ng/ml range when exposed to plant mitogen, bacterial endotoxin, virus or IL-1. Although the radioimmunoassay was more sensitive than the chemotaxis assay (detection limit 0.6 ng/ml versus 10 ng/ml) a correlation between concentrations of immunoreactive IL-8 and neutrophil chemotactic activity in the supernatants from stimulated monocytes and fibroblasts was observed. In synovial fluids from patients with inflammatory joint disease, IL-8 was clearly demonstrable, but there was no correlation between IL-8 levels and general parameters of disease activity (erythrocyte sedimentation rate and serum levels of C-reactive protein). Synovial fluids from patients with rheumatoid arthritis, seropositive for rheumatoid factor, contained significantly higher concentrations of IL-8 than synovial fluids from seronegative rheumatoid arthritis patients and patients with non-rheumatoid arthritis joint inflammation. There was a highly significant correlation between IL-8 levels and serum titers of rheumatoid factor. These findings suggest that the molecular mechanisms underlying joint inflammation may be distinct in different types of arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583890

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

Review 1.  Chemokines in rheumatoid arthritis.

Authors:  Z Szekanecz; R M Strieter; S L Kunkel; A E Koch
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  Cytokines in rheumatoid arthritis. Potential targets for pharmacological intervention.

Authors:  Z Szekanecz; A E Koch; S L Kunkel; R M Strieter
Journal:  Drugs Aging       Date:  1998-05       Impact factor: 3.923

3.  Relationship between interleukin-8 and neutrophil adhesion molecules in rheumatoid arthritis.

Authors:  C M De Gendt; L S De Clerck; C H Bridts; N Van Osselaer; W J Stevens
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

Review 4.  Novel aspects of inflammation: interleukin-8 and related chemotactic cytokines.

Authors:  M Baggiolini
Journal:  Clin Investig       Date:  1993-10

5.  Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model.

Authors:  K Sato; C L Liebeler; M K Quartey; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

Review 6.  Alterations of the mucosal immune system in inflammatory bowel disease.

Authors:  R P MacDermott
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

7.  Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model.

Authors:  K Sato; M K Quartey; C L Liebeler; C T Le; G S Giebink
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

8.  Interleukin-8 activates microtubule-associated protein 2 kinase (ERK1) in human neutrophils.

Authors:  J Van Lint; J Van Damme; A Billiau; W Merlevede; J R Vandenheede
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

9.  TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.

Authors:  Asuka Inoue; Isao Matsumoto; Yuki Tanaka; Naoto Umeda; Chinatsu Takai; Hoshimi Kawaguchi; Hiroshi Ebe; Hiroto Yoshida; Yoshihiro Matsumoto; Seiji Segawa; Satoru Takahashi; Takayuki Sumida
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

10.  Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xianjin Zhu; Lianbo Xiao; Rongfen Huo; Jie Zhang; Jinpiao Lin; Jun Xie; Songtao Sun; Yong He; Yue Sun; Zhou Zhou; Baihua Shen; Ningli Li
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.